Showing posts with label Platelet Rich Plasma market. Show all posts
Showing posts with label Platelet Rich Plasma market. Show all posts

Wednesday, 12 August 2015

Promise of Fast Recovery Behind Rising Popularity of Platelet-rich-plasma Therapies


Platelet-rich-plasma (PRP) is a volume of autologous plasma with concentration of platelets above the average level. PRP is touted as a breakthrough product in the field of bone and soft tissue healing, a relatively new product of biotechnology that is gaining increased interest in cellular therapy and tissue engineering.

PRP therapy is widely touted as a natural pain management technique that aids in speeding-up the healing process of our body. Initially, PRP therapy was used after spinal surgeries to speed-up the process of bone healing. Later on, facial and oral surgeons started using the technique to regrow bones after surgeries such as facial reconstruction and bone grafting. The technique is now used in a vast variety of injuries, conditions such as tendonitis, chronic pain, and more. More importantly, PRP therapy is used on a huge scale for treating sports injuries in athletes.

Browse Market Research Report of Platelet Rich Plasma Market: http://www.transparencymarketresearch.com/platelet-rich-plasma-market.html

A Treatment Method that Holds Great Promise of Fast Recovery
PRP therapy promises positive results in terms of enhanced healing response of the body. By directing platelets precisely at the site of injury, PRP therapy increases the chances of optimal tissue restoration. However currently, research studies to support these promises are lacking. The popularity of the technique is therefore, not very widespread and adoption is rather sparse. Even though the success rates of PRP therapy are questionable, only a few risks are associated with it such as the possibility of increased pain at the site of injection. Possibility of occurrence of other problems such as tissue damage, nerve injuries, and infection is not much different from that related with treatment by the virtue of cortisone injections.

PRP therapies are known to prove especially more beneficial in injury sites that do not have enough supply of blood, such as ligaments and tendons. Traditionally, treatment of such structures often requires invasive therapies. PRP therapy is a much less invasive treatment alternative. By using a fluoroscope or an ultrasound, physicians can inject platelet-rich-plasma at the site of injury in a very precise manner. The platelets begin to speed-up the process of healing immediately upon injection, leading to rapid recovery. No supplementary medication or chemicals are involved in a PRP therapy, so the chances of causing side effects is very rare.

Browse Market Research Press Release of Platelet Rich Plasma Market: http://www.transparencymarketresearch.com/pressrelease/platelet-rich-plasma-market.htm

.. And thus Demand is Rapidly Rising
According to a market research report published by Transparency Market Research, the global market for platelet-rich plasma was valued at US$16 million in 2013. Rise in therapies utilizing PRP across the globe, especially from the fields of sports injuries, orthopedic injuries, and cosmetic surgeries, is expected to drive the market at 11.9% CAGR between 2014 and 2020. This will allow the market to reach a valuation of nearly US$35 million by 2020.

While a rising number of orthopedic diseases and sports injuries across the globe is the greatest demand driver of PRP therapies, technological development and quickened regulatory processes for the approval of new equipment and devices are also benefitting the global PRP market.

On the flip side, the high costs associated with PRP therapies, plasma products, facilitating devices, and threat of failure of therapies are factors hampering growth of the market globally.

Nevertheless, the market in the near future will benefit from the rising number of research studies establishing the efficiency of PRP therapies and the rising adoption of these therapies by leading sportspersons across the globe. Furthermore, the market will also benefit from technological advancements in PRP therapy facilitating devices and introduction of innovative techniques for administering platelet-rich-plasma. Such factors will boost the global platelet rich plasma market in the near future. 

Wednesday, 15 July 2015

Global Platelet Rich Plasma Market: Trends Defining Future Performance

The global platelet rich plasma (PRP) market is witnessing immense growth on account of a rapid rise in demand for therapies utilizing PRP. Awareness regarding the benefits of PRP therapy is attracting a larger consumer base.

According to a report published by Transparency Market Research, the global platelet rich plasma market had reached a value of US$16 million in 2013. Expanding at a healthy CAGR of 11.9% during the period of 2014-2020, this market is poised to reach around US$35 million by the end of the forecast period.

Browse The Market Research Report of Platelet Rich Plasma Market: 

Let’s take a look at what is trending in the global platelet rich plasma market:

  • The P-PRP market emerged as the leading segment among all the PRP products in the market in 2013. This market occupied more than 60% of the overall market that year. P-PRP is the traditional type of platelet rich plasma, which is the main reason behind the growth of this market segment.

  • In the coming years, the L-PRP market is projected to post the fastest growth on account of the huge number of leukocytes and stem cells that speed up the healing process of injuries.

  • Among applications, orthopedic surgery dominated the global market in 2013, holding around 30% of the market. The prevalence of orthopedic and sports injuries, coupled with the global rise in geriatric population, is the major cause that has led to the growth of this market, as PRP therapy is highly efficient in the treatment of orthopedic injuries.

  • Currently, the market for cosmetic surgeries is also witnessing extensive growth on account of the various applications of PRP in cosmetic surgeries. The cost-efficiency of PRP therapies is another factor drawing the interest of customers toward the treatment, significantly fueling the market.

  • Autologus PRP was the biggest segment of the global PRP market based on its origin in 2013. However, the market is losing ground to PRP products and therapies of allogenic origin. The allogenic PRP market is likely to report the highest growth rate in the near future. The lesser time taken by allogenic PRP to heal a wound is the key reason why people are getting more interested in it.

  • North America is the traditional market for PRP on account of the presence of a large base of major players in the region. The region occupied over 50% of the global market in 2013. The rising number of orthopedic and cosmetic surgeries and increasing awareness regarding PRP products and therapies in North America is helping the market register strong business.

  • In recent times, the PRP market in Asia Pacific has showed huge potential and emerged as a lucrative industry. Owing to the robust development, the market is poised to witness the fastest growth in the coming years. The rapid rise in medical tourism, ample availability of domestic players, presence of a large base of geriatric population, and the increasing awareness pertaining to PRP therapies is expected to push the Asia Pacific PRP market.

Browse The Press Release of Platelet Rich Plasma Market: 
http://www.transparencymarketresearch.com/pressrelease/platelet-rich-plasma-market.htm

The global PRP market is led by Biomet, Harvest Technologies, Arteriocyte Medical Systems Inc., and Arthrex Inc. Innovating effective PRP products together with a broad distribution network is the key to success in this market.